Detalhe da pesquisa
1.
Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation.
J Infect Dis
; 228(3): 321-331, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254795
2.
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.
Thorax
; 77(6): 581-588, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706982
3.
Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis.
Antimicrob Agents Chemother
; 65(2)2021 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139284
4.
In Vitro Activities of ß-Lactam-ß-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611364
5.
From gut to lung and back again: early life microbiota in cystic fibrosis.
Eur Respir J
; 63(5)2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724179
6.
Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro.
PLoS One
; 19(5): e0303516, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728330
7.
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Ann Am Thorac Soc
; 21(4): 595-603, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963297
8.
Good cop, bad cop: anaerobes in cystic fibrosis airways.
Eur Respir J
; 52(1)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997183
9.
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
bioRxiv
; 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546739
10.
Airway bacterial community composition in persons with advanced cystic fibrosis lung disease.
J Cyst Fibros
; 22(4): 623-629, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628831
11.
Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes.
J Cyst Fibros
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244842
12.
The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation.
J Pediatric Infect Dis Soc
; 11(Supplement_2): S40-S45, 2022 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069900
13.
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation.
Clin Chest Med
; 43(4): 647-665, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344072
14.
Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.
mSphere
; 7(3): e0010422, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477313
15.
Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
J Cyst Fibros
; 21(5): 766-768, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667975
16.
Tenets of a holistic approach to drinking water-associated pathogen research, management, and communication.
Water Res
; 211: 117997, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999316
17.
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection.
ERJ Open Res
; 7(2)2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33898611
18.
Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
Pediatr Pulmonol
; 56(12): 3634-3643, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983680
19.
Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.
J Cyst Fibros
; 20(6): 926-931, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612403
20.
Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis.
J Cyst Fibros
; 20(2): 310-315, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747193